164 related articles for article (PubMed ID: 4074607)
1. Comparison of two slow-release formulations of metoprolol with conventional metoprolol and atenolol in hypertensive patients.
Silas JH; Freestone S; Lennard MS; Ramsay LE
Br J Clin Pharmacol; 1985 Oct; 20(4):387-91. PubMed ID: 4074607
[TBL] [Abstract][Full Text] [Related]
2. Atenolol and metoprolol once daily in hypertension.
Scott AK; Rigby JW; Webster J; Hawksworth GM; Petrie JC; Lovell HG
Br Med J (Clin Res Ed); 1982 May; 284(6328):1514-6. PubMed ID: 6805588
[TBL] [Abstract][Full Text] [Related]
3. A double-blind comparison of metoprolol CR/ZOK 50 mg and atenolol 50 mg once daily for uncomplicated hypertension.
Klein G; Berger J; Olsson G; Menzel T
J Clin Pharmacol; 1990 Feb; 30(S2):S72-7. PubMed ID: 2179284
[TBL] [Abstract][Full Text] [Related]
4. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
Floras JS; Jones JV; Hassan MO; Sleight P
Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
[TBL] [Abstract][Full Text] [Related]
5. A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensives.
Nilsson OR; Atterhög JH; Castenfors J; Jorfelt L; Karlberg BE; Thulin T; Tolagen K; Wettre S; Ohman KP
Acta Med Scand; 1984; 216(3):301-7. PubMed ID: 6388253
[TBL] [Abstract][Full Text] [Related]
6. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
Plosker GL; Clissold SP
Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
[TBL] [Abstract][Full Text] [Related]
7. Atenolol is associated with lower day-of-surgery heart rate compared to long- and short-acting metoprolol.
Schonberger RB; Brandt C; Feinleib J; Dai F; Burg MM
J Cardiothorac Vasc Anesth; 2013 Apr; 27(2):298-304. PubMed ID: 22889605
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing.
Freestone S; Silas JH; Lennard MS; Ramsay LE
Br J Clin Pharmacol; 1982 Nov; 14(5):713-8. PubMed ID: 7138751
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of atenolol and metoprolol in the treatment of hypertension.
Rasmussen S; Arnung K; Eskildsen PC; Nielsen PE
Br J Clin Pharmacol; 1981 Dec; 12(6):887-91. PubMed ID: 7340890
[TBL] [Abstract][Full Text] [Related]
10. Treatment with beta-blockers--the value of an even plasma concentration over 24 h.
Agewall S; Kendall M
J Clin Pharm Ther; 1997 Jun; 22(3):171-9. PubMed ID: 9447471
[TBL] [Abstract][Full Text] [Related]
11. Duration of beta-blockade with metoprolol and atenolol: influence of drug oxidation.
Freestone S; Lennard MS; Silas JH; Ramsay LE
Postgrad Med J; 1983; 59 Suppl 3():36-7. PubMed ID: 6647208
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the duration of antihypertensive action of atenolol and metoprolol over a 24-hour period.
Crowe PF; Ferguson RJ
Curr Med Res Opin; 1985; 9(7):431-5. PubMed ID: 4028805
[TBL] [Abstract][Full Text] [Related]
13. A double-blind comparison of once-daily metoprolol controlled-release and atenolol in the treatment of Chinese patients with mild to moderate hypertension.
Chen MF; Yang CY; Chen WJ; Lee CM; Wu CC; Liau CS; Lee YT
Cardiovasc Drugs Ther; 1995 Jun; 9(3):401-6. PubMed ID: 8527349
[TBL] [Abstract][Full Text] [Related]
14. Comparison of CNS-related subjective symptoms in hypertensive patients treated with either a new controlled release (CR/ZOK) formulation of metoprolol or atenolol.
Dimenäs E; Ostergren J; Lindvall K; Dahlöf C; Westergren G; de Faire U
J Clin Pharmacol; 1990 Feb; 30(S2):S82-90. PubMed ID: 2179286
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of atenolol, metoprolol, metoprolol durules, and slow-release oxprenolol in essential hypertension.
Wilcox RG; Hampton JR
Br Heart J; 1981 Nov; 46(5):498-502. PubMed ID: 6119103
[TBL] [Abstract][Full Text] [Related]
16. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
Lyngstam O; Rydén L
Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
[TBL] [Abstract][Full Text] [Related]
17. A comparison of once daily atenolol and metoprolol SA in mild to moderate hypertension.
Morley CA; Cavalcanti C; Perrins EJ; Sutton R
Br J Clin Pharmacol; 1983 Jun; 15(6):715-7. PubMed ID: 6347229
[TBL] [Abstract][Full Text] [Related]
18. The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients.
Ravid M; Lang R; Jutrin I
Arch Intern Med; 1985 Jul; 145(7):1321-3. PubMed ID: 4015285
[TBL] [Abstract][Full Text] [Related]
19. A comparison of once-daily atenolol and metoprolol using office and ambulatory blood pressure monitoring.
Rutan GH; Feig PU; May S; Kriegman AG; Brady EM
J Clin Pharmacol; 1993 May; 33(5):418-26. PubMed ID: 8331198
[TBL] [Abstract][Full Text] [Related]
20. Metabolic effects of controlled-release metoprolol in hypertensive men with impaired or diabetic glucose tolerance: a comparison with atenolol.
Fagerberg B; Berglund A; Holme E; Wilhelmsen L; Elmfeldt D
J Intern Med; 1990 Jan; 227(1):37-43. PubMed ID: 2405089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
